News | January 26, 2024
Syngene Q3 FY 24 PAT up 4% to Rs 115 Cr
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
The company is confident of addressing all the observations within the stipulated time
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
Profit after tax (before exceptional items) up 23% to Rs 215 crores
The USFDA inspectors issued the observations after a product pre-approval inspection of the biologics facility in Bachupally
Subscribe To Our Newsletter & Stay Updated
